Kasper Kristoffersen

Kasper Kristoffersen has extensive work experience in the pharmaceutical industry. Kasper started their career at Pharmexa A/S in 2007 as a Corporate Affairs Analyst and Business Analyst. Kasper then moved on to Genmab as a Senior Manager in Portfolio Management in 2008, and later joined Nycomed Group as a Business Analysis Manager in Corporate Business Development from 2009 to 2011. Following this, they worked at Takeda Pharmaceutical Company Ltd as a Business Analysis Manager in Global Licensing & Business Development in 2011. Kasper then joined Vifor Pharma in 2012, where they held positions as Director of Business Development Europe and later Director of Global Business Development until 2017. Kasper is currently employed at Tillotts Pharma AG as an Associate Director, first in Business Development & Licensing from 2017 to 2021 and then in Corporate Development from 2021 onwards.

Kasper Kristoffersen's education history includes:

- Executive Programme: Corporate Strategy and Mergers & Acquisitions at INSEAD in 2014.

- The Pharma Business Development Course at the Centre for Executive Leadership (C.E.L. for Pharma) in 2012.

- The Pharma Brand Planning Course at the Centre for Executive Leadership (C.E.L. for Pharma) in 2011.

- LIF courses in Biochemistry, Microbiology, Pharmacology, and Pharmaceutical Law at The Danish Association of the Pharmaceutical Industry from 2007 to 2008.

- M.Sc. in Economics and Business Administration from Copenhagen Business School from 2004 to 2006.

- MBA courses in Economics and Management at Central European University in 2005.

- B.Sc. in Economics and Business Administration from Copenhagen Business School from 2001 to 2004.

- High School education at West Carrolton High School, Dayton, Ohio, USA from 1994 to 1995.

- Education at Maribo Borgerskole.